Bonti's Series B Round

Bonti raised a round of funding on January 04, 2017.

Bonti, formerly Endurance Biotech, is focused on developing next generation neurotoxins through its proprietary platform for treating indications with strong unmet needs.…

Articles about Bonti's Series B Round: